Young patients with myelofibrosis commonly exhibit inflammatory comorbidities

Andrew Kuykendall, MD, Moffitt Cancer Center, Tampa, FL, discusses a study demonstrating that young patients with myelofibrosis (MF) commonly exhibit inflammatory comorbidities. Dr Kuykendall highlights the possible importance of managing these conditions, as inflammation is likely a driver of disease progression in patients. This interview took place at the 1st Annual MPN Workshop of the Carolinas in Asheville, NC.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.